| Date Filed | Type | Description |
| 08/24/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.9% stake in Gamida Cell Ltd. |
| 08/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.8% stake in IO Biotech, Inc. |
| 08/16/2023 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 08/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/10/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Alimera Sciences, Inc. |
| 06/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.4% stake in Evolus, Inc. |
| 06/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Aytu BioPharma, Inc. |
| 06/09/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.6% stake in Scynexis, Inc. |
| 04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/18/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.3% stake in Third Harmonic Bio, Inc. |
| 12/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 5.3% stake in Exagen Inc. |
| 02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 10% stake in CTI BioPharma Corp. |
| 02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 6.5% stake in Apollo Endosurgery, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 7.9% stake in Conformis, Inc. |
| 02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 0% stake in Yumanity Therapeutics, Inc. |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|